These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 27930981)
1. Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell. Xie Q; Wen H; Zhang Q; Zhou W; Lin X; Xie D; Liu Y Biomed Pharmacother; 2017 Jan; 85():16-21. PubMed ID: 27930981 [TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway. Jiang J; Yuan Z; Sun Y; Bu Y; Li W; Fei Z Biomed Pharmacother; 2017 Dec; 96():619-625. PubMed ID: 29035827 [TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg3 enhances the radiosensitivity of lung cancer A549 and H1299 cells via the PI3K/AKT signaling pathway. Li J; Yang B In Vitro Cell Dev Biol Anim; 2023 Jan; 59(1):19-30. PubMed ID: 36790693 [TBL] [Abstract][Full Text] [Related]
4. 20(R)-ginsenoside Rg3, a rare saponin from red ginseng, ameliorates acetaminophen-induced hepatotoxicity by suppressing PI3K/AKT pathway-mediated inflammation and apoptosis. Zhou YD; Hou JG; Liu W; Ren S; Wang YP; Zhang R; Chen C; Wang Z; Li W Int Immunopharmacol; 2018 Jun; 59():21-30. PubMed ID: 29621733 [TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway. Cao Y; Ye Q; Zhuang M; Xie S; Zhong R; Cui J; Zhou J; Zhu Y; Zhang T; Cao L PLoS One; 2017; 12(11):e0186520. PubMed ID: 29140979 [TBL] [Abstract][Full Text] [Related]
6. Ginsenosides Inhibit the Proliferation of Lung Cancer Cells and Suppress the Rate of Metastasis by Modulating EGFR/VEGF Signaling Pathways. Yu X; Wang Q; Dai Z J Oleo Sci; 2024; 73(2):219-230. PubMed ID: 38311411 [TBL] [Abstract][Full Text] [Related]
7. Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway. Lu M; Fei Z; Zhang G Biomed Pharmacother; 2018 Jan; 97():1282-1288. PubMed ID: 29156516 [TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg3 enhances the anticancer effect of 5‑FU in colon cancer cells via the PI3K/AKT pathway. Hong S; Cai W; Huang Z; Wang Y; Mi X; Huang Y; Lin Z; Chen X Oncol Rep; 2020 Oct; 44(4):1333-1342. PubMed ID: 32945504 [TBL] [Abstract][Full Text] [Related]
9. The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivo by mediating apoptosis and autophagy through regulation of the PI3K/Akt/mTOR pathway. Liu H; Zhao J; Fu R; Zhu C; Fan D PLoS One; 2019; 14(5):e0216759. PubMed ID: 31091245 [TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rg3 Suppresses Proliferation and Induces Apoptosis in Human Osteosarcoma. Li Y; Lu J; Bai F; Xiao Y; Guo Y; Dong Z Biomed Res Int; 2018; 2018():4306579. PubMed ID: 29750154 [TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1. Li J; Qi Y Exp Mol Pathol; 2019 Feb; 106():131-138. PubMed ID: 30633886 [TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg3 regulates DNA damage in non-small cell lung cancer cells by activating VRK1/P53BP1 pathway. Liu T; Zuo L; Guo D; Chai X; Xu J; Cui Z; Wang Z; Hou C Biomed Pharmacother; 2019 Dec; 120():109483. PubMed ID: 31629252 [TBL] [Abstract][Full Text] [Related]
13. Rare Ginsenoside 20(R)-Rg3 Inhibits D-Galactose-Induced Liver and Kidney Injury by Regulating Oxidative Stress-Induced Apoptosis. Li W; Wang JQ; Zhou YD; Hou JG; Liu Y; Wang YP; Gong XJ; Lin XH; Jiang S; Wang Z Am J Chin Med; 2020; 48(5):1141-1157. PubMed ID: 32668974 [TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling. Yang X; Zou J; Cai H; Huang X; Yang X; Guo D; Cao Y Biomed Pharmacother; 2017 Dec; 96():1240-1245. PubMed ID: 29169725 [TBL] [Abstract][Full Text] [Related]
15. [Effect of ginsenoside Rg3 on Pim-3 and Bad proteins in human pancreatic cancer cell line PANC-1]. Jian J; Hu ZF; Huang Y Ai Zheng; 2009 May; 28(5):461-5. PubMed ID: 19624871 [TBL] [Abstract][Full Text] [Related]
16. 20(s)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/Akt and XIAP pathways. Wang JH; Nao JF; Zhang M; He P Tumour Biol; 2014 Dec; 35(12):11985-94. PubMed ID: 25168366 [TBL] [Abstract][Full Text] [Related]
17. Protective effect of ginsenoside Rg3 on lung injury in diabetic rats. Wang H; Wu W; Wang G; Xu W; Zhang F; Wu B; Tian Y J Cell Biochem; 2019 Mar; 120(3):3323-3330. PubMed ID: 30362612 [TBL] [Abstract][Full Text] [Related]
18. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells. Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357 [TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rg5 induces apoptosis and autophagy via the inhibition of the PI3K/Akt pathway against breast cancer in a mouse model. Liu Y; Fan D Food Funct; 2018 Nov; 9(11):5513-5527. PubMed ID: 30207362 [TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer. Yuan Z; Jiang H; Zhu X; Liu X; Li J Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]